602 related articles for article (PubMed ID: 31226298)
1. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis.
Sudhof LS; Shainker SA; Einerson BD
Am J Obstet Gynecol; 2019 Sep; 221(3):275.e1-275.e12. PubMed ID: 31226298
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid for the treatment of postpartum hemorrhage: a cost-effectiveness analysis.
Howard DC; Jones AE; Skeith A; Lai J; D'Souza R; Caughey AB
Am J Obstet Gynecol MFM; 2022 May; 4(3):100588. PubMed ID: 35124299
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.
Li B; Miners A; Shakur H; Roberts I;
Lancet Glob Health; 2018 Feb; 6(2):e222-e228. PubMed ID: 29389542
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid for the prevention of postpartum hemorrhage: a cost-effectiveness analysis.
Dazelle WDH; Ebner MK; Kazma J; Potarazu SN; Ahmadzia HK
J Thromb Thrombolysis; 2023 Jul; 56(1):128-136. PubMed ID: 37133702
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial.
Durand-Zaleski I; Deneux-Tharaux C; Seco A; Malki M; Frenkiel J; Sentilhes L;
BJOG; 2021 Jan; 128(1):114-120. PubMed ID: 32770781
[TBL] [Abstract][Full Text] [Related]
6. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
Trials; 2010 Apr; 11():40. PubMed ID: 20398351
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and budget impact of adding tranexamic acid for management of post-partum hemorrhage in the Indian public health system.
Joshi BN; Shetty SS; Moray KV; Chaurasia H; Sachin O
BMC Pregnancy Childbirth; 2023 Jan; 23(1):9. PubMed ID: 36609241
[TBL] [Abstract][Full Text] [Related]
8. Does tranexamic acid reduce mortality in women with postpartum hemorrhage?
Dresang L; Kredit S; Vellardita L
J Fam Pract; 2019 Nov; 68(9):E12-E13. PubMed ID: 31725142
[TBL] [Abstract][Full Text] [Related]
9. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of tranexamic acid for treatment of postpartum hemorrhage: A systematic review.
Aziz S; Rossiter S; Homer CSE; Wilson AN; Comrie-Thomson L; Scott N; Vogel JP
Int J Gynaecol Obstet; 2021 Dec; 155(3):331-344. PubMed ID: 33621351
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial.
Guerriero C; Cairns J; Perel P; Shakur H; Roberts I;
PLoS One; 2011 May; 6(5):e18987. PubMed ID: 21559279
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid to reduce postpartum hemorrhage: A MANDATE systematic review and analyses of impact on maternal mortality.
McClure EM; Jones B; Rouse DJ; Griffin JB; Kamath-Rayne BD; Downs A; Goldenberg RL
Am J Perinatol; 2015 Apr; 32(5):469-74. PubMed ID: 25289705
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial.
Ortuanya KE; Eleje GU; Ezugwu FO; Odugu BU; Ikechebelu JI; Ugwu EO; Eke AC; Awkadigwe FI; Ezenwaeze MN; Ofor IJ; Okafor CC; Okafor CG
Womens Health (Lond); 2024; 20():17455057231225311. PubMed ID: 38279808
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid for reduction of blood loss after Caesarean delivery: a cost-effectiveness analysis of the TRAAP2 trial.
Sentilhes L; Bénard A; Madar H; Froeliger A; Petit S; Deneux-Tharaux C;
Br J Anaesth; 2023 Nov; 131(5):893-900. PubMed ID: 37690946
[TBL] [Abstract][Full Text] [Related]
15. TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial - a study protocol.
Sentilhes L; Daniel V; Deneux-Tharaux C;
BMC Pregnancy Childbirth; 2020 Jan; 20(1):63. PubMed ID: 32005192
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid for childbirth: why, when, and for whom.
Sentilhes L; Madar H; Mattuizzi A; Froeliger A; Merlot B; Elleboode B; Deneux-Tharaux C
Expert Rev Hematol; 2019 Sep; 12(9):753-761. PubMed ID: 31295414
[No Abstract] [Full Text] [Related]
17. Should we add tranexamic acid to postpartum haemorrhage protocols after the WOMAN trial publication?
Ducloy-Bouthors AS; Godier A
Anaesth Crit Care Pain Med; 2018 Aug; 37(4):303-304. PubMed ID: 28927736
[No Abstract] [Full Text] [Related]
18. The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial.
Nishijima DK; Kuppermann N; Roberts I; VanBuren JM; Tancredi DJ
Ann Emerg Med; 2019 Jul; 74(1):79-87. PubMed ID: 30642657
[TBL] [Abstract][Full Text] [Related]
19. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
WOMAN Trial Collaborators
Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
